Client: Medical University of South Carolina (MUSC)
Partnership Since: 2021
Robotic Systems Sold: da Vinci Xi (sold in 2021, capital reinvested toward new system)
The Medical University of South Carolina (MUSC), a leading academic medical center, needed to reallocate funds to support a growing robotic surgery program under a per-click model. The OEM did not offer a trade-in on their da Vinci Xi system, only a consumables discount. After evaluating alternatives, MUSC determined a third-party sale would yield better financial results. Partnering with R2 Surgical allowed MUSC to unlock more capital value than vendor discounts, enabling reinvestment into both consumables and a new surgical robot.
As MUSC expanded its robotic fleet, leadership needed to optimize capital and operational budgets. The shift to a per-click model meant increased consumables spending. MUSC needed a trusted, transparent partner to facilitate the sale and secure a fair market return.
R2 Surgical began by helping MUSC obtain a fair market value appraisal for the da Vinci Xi robot. They reached out to their vast network, generating multiple competitive offers. After careful vetting and negotiation, R2 Surgical secured a high-value sale that outperformed the OEM's consumables discount. The team also facilitated live video inspections and handled logistics, including packaging, accessories, and equipment removal, which provided a seamless, low-stress experience.
MUSC aims to further optimize capital equipment lifecycle management by continuing to work with R2 Surgical for future robotic system sales and acquisitions. They are also committed to extending their global mission through responsible donations of surplus equipment.
"Working with R2 Surgical was incredibly smooth and pleasant. Tom and his team were accommodating, worked around our schedule, and kept us informed every step of the way. The thorough equipment inspections and transparent communication gave us confidence that the robot was going to a good home and being sold for fair market value. The capital we recovered allowed us to purchase a new surgical robot — a true win for our institution."